MRUS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.57%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,392,792.00

Merus Insider Trading History Chart

Merus Share Price & Price History

^$51.70

▼ -3.44 (-6.24%)

As of 05/27/2025 04:05 PM ET

Days: 30 | 90 | 365

Merus Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/27/2024	Peter B. Silverman	COO	Sell	10,000	$60.00	$600,000.00
6/12/2024	Harry Shuman	VP	Sell	7,300	$57.84	$422,232.00	7,002
6/10/2024	Harry Shuman	VP	Sell	1,000	$53.22	$53,220.00	7,002
6/4/2024	Harry Shuman	VP	Sell	6,000	$52.89	$317,340.00	7,002
12/19/2023	Harry Shuman	VP	Sell	115	$26.68	$3,068.20	7,002
12/15/2023	Peter B. Silverman	COO	Sell	22,386	$25.00	$559,650.00
12/1/2023	Harry Shuman	VP	Sell	575	$24.58	$14,133.50	7,367
6/1/2023	Harry Shuman	VP	Sell	575	$21.48	$12,351.00	5,442
12/13/2022	Harry Shuman	VP	Sell	168	$13.85	$2,326.80	3,517
12/1/2022	Harry Shuman	VP	Sell	575	$15.35	$8,826.25	3,685
11/3/2022	Sven Ante Lundberg	CEO	Buy	14,706	$14.38	$211,472.28	40,576
8/25/2022	Harry Shuman	VP	Sell	165	$24.33	$4,014.45	1,760
8/22/2022	Sven Ante Lundberg	CEO	Buy	5,826	$22.92	$133,531.92	25,870
8/19/2022	Sven Ante Lundberg	CEO	Buy	704	$22.99	$16,184.96	20,044
7/12/2022	Sven Ante Lundberg	CEO	Buy	4,340	$22.97	$99,689.80	19,340

See Full Table

SEC Filings (Institutional Ownership Changes) for Merus (NASDAQ:MRUS)

96.14% of Merus stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Merus Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	112,522	$4.74M	0.0%	+14.0%	0.163%
5/16/2025	Woodline Partners LP	1,400,171	$58.93M	0.4%	+17.8%	2.023%
5/16/2025	Fred Alger Management LLC	47,956	$2.02M	0.0%	+1.4%	0.069%
5/16/2025	Goldman Sachs Group Inc.	124,795	$5.25M	0.0%	-48.5%	0.180%
5/16/2025	Samlyn Capital LLC	2,379,428	$100.15M	1.5%	-10.8%	3.438%
5/16/2025	Parkman Healthcare Partners LLC	28,230	$1.19M	0.1%	-38.2%	0.041%
5/16/2025	Polar Asset Management Partners Inc.	12,998	$0.55M	0.0%	-58.5%	0.019%
5/16/2025	Millennium Management LLC	586,434	$24.68M	0.0%	-33.6%	0.847%
5/16/2025	Granahan Investment Management LLC	95,720	$4.03M	0.2%	-8.5%	0.138%
5/16/2025	Cinctive Capital Management LP	12,361	$0.52M	0.0%	N/A	0.018%
5/16/2025	Boothbay Fund Management LLC	160,000	$6.73M	0.2%	+100.0%	0.231%
5/16/2025	Alliancebernstein L.P.	739,288	$31.12M	0.0%	-7.2%	1.068%
5/16/2025	AQR Capital Management LLC	23,097	$0.97M	0.0%	-3.1%	0.033%
5/16/2025	Allostery Investments LP	124,657	$5.25M	7.6%	+473.5%	0.180%
5/16/2025	Ally Bridge Group NY LLC	77,896	$3.28M	2.9%	-33.3%	0.113%
5/16/2025	Alyeska Investment Group L.P.	68,182	$2.87M	0.0%	-50.0%	0.099%
5/16/2025	ADAR1 Capital Management LLC	66,960	$2.82M	0.5%	-17.8%	0.097%
5/15/2025	Baker BROS. Advisors LP	223,500	$9.41M	0.1%	-50.3%	0.323%
5/15/2025	Paradigm Biocapital Advisors LP	3,369,699	$141.83M	6.7%	+99.4%	4.869%
5/15/2025	DAFNA Capital Management LLC	461,804	$19.44M	5.5%	+2.2%	0.667%
5/15/2025	Driehaus Capital Management LLC	1,254,149	$52.79M	0.5%	-2.0%	1.812%
5/15/2025	Siren L.L.C.	1,043,467	$43.92M	2.5%	+33.0%	1.508%
5/15/2025	Trexquant Investment LP	62,382	$2.63M	0.0%	-38.1%	0.090%
5/15/2025	Tri Locum Partners LP	156,915	$6.61M	3.4%	-54.8%	0.227%
5/14/2025	Affinity Asset Advisors LLC	321,962	$13.55M	1.3%	-17.3%	0.465%
5/14/2025	Walleye Capital LLC	14,704	$0.62M	0.0%	N/A	0.021%
5/14/2025	Price T Rowe Associates Inc. MD	1,095,742	$46.12M	0.0%	-1.9%	1.583%
5/14/2025	T. Rowe Price Investment Management Inc.	509,761	$21.46M	0.0%	-37.0%	0.736%
5/14/2025	Carmignac Gestion	121,161	$5.13M	0.1%	N/A	0.175%
5/14/2025	Wellington Management Group LLP	4,718,172	$198.59M	0.0%	+34.9%	6.817%
5/13/2025	Algert Global LLC	107,101	$4.51M	0.1%	-38.1%	0.155%
5/13/2025	Aberdeen Group plc	172,063	$7.24M	0.0%	+97.3%	0.249%
5/13/2025	Caitong International Asset Management Co. Ltd	1,794	$76K	0.1%	+955.3%	0.003%
5/12/2025	Invesco Ltd.	828,217	$34.86M	0.0%	+5.3%	1.197%
5/12/2025	Swiss National Bank	92,854	$3.91M	0.0%	-1.2%	0.134%
5/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	6,101	$0.26M	0.0%	+9.1%	0.009%
5/9/2025	CenterBook Partners LP	91,088	$3.83M	0.2%	-36.2%	0.132%
5/9/2025	Westfield Capital Management Co. LP	1,501,220	$63.19M	0.3%	+51.2%	2.170%
5/9/2025	BIT Capital GmbH	29,612	$1.25M	0.1%	+38.4%	0.043%
5/9/2025	PNC Financial Services Group Inc.	5,800	$0.24M	0.0%	+30.0%	0.008%
5/8/2025	US Bancorp DE	2,935	$0.12M	0.0%	+324.1%	0.004%
5/8/2025	Federated Hermes Inc.	1,044,625	$43.97M	0.1%	-34.4%	1.510%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	13,367	$0.56M	0.0%	-3.0%	0.019%
5/7/2025	TD Asset Management Inc	71,258	$3M	0.0%	-5.3%	0.103%
5/7/2025	Knights of Columbus Asset Advisors LLC	13,785	$0.58M	0.0%	+2.7%	0.020%
5/6/2025	KLP Kapitalforvaltning AS	9,100	$0.38M	0.0%	-11.7%	0.013%
5/5/2025	Allianz Asset Management GmbH	15,600	$0.66M	0.0%	+34.5%	0.023%
5/5/2025	Atle Fund Management AB	35,292	$1.49M	0.7%	-43.6%	0.051%
5/2/2025	TimesSquare Capital Management LLC	343,705	$14.47M	0.2%	+3.8%	0.497%
4/30/2025	Alps Advisors Inc.	51,020	$2.15M	0.0%	-7.8%	0.074%
4/30/2025	China Universal Asset Management Co. Ltd.	13,858	$0.58M	0.1%	-4.5%	0.020%
4/29/2025	Envestnet Asset Management Inc.	13,984	$0.59M	0.0%	N/A	0.020%
4/29/2025	Bank of New York Mellon Corp	34,713	$1.46M	0.0%	-3.7%	0.050%
4/29/2025	GF Fund Management CO. LTD.	1,753	$74K	0.0%	+21.9%	0.003%
4/29/2025	Moody Aldrich Partners LLC	108,281	$4.56M	1.0%	+273.4%	0.157%
4/28/2025	Teacher Retirement System of Texas	12,898	$0.54M	0.0%	-8.9%	0.019%
4/25/2025	KBC Group NV	2,901	$0.12M	0.0%	-94.9%	0.004%
4/17/2025	Exchange Traded Concepts LLC	2,698	$0.11M	0.0%	-19.1%	0.004%
4/15/2025	Net Worth Advisory Group	5,054	$0.21M	0.1%	N/A	0.007%
4/15/2025	Avanza Fonder AB	2,749	$0.12M	0.0%	N/A	0.004%
4/14/2025	Harbor Capital Advisors Inc.	64,374	$2.71M	0.1%	+49.0%	0.093%
4/7/2025	GAMMA Investing LLC	631	$27K	0.0%	+2,153.6%	0.001%
3/18/2025	California State Teachers Retirement System	41,149	$1.73M	0.0%	+7.5%	0.060%
2/25/2025	Polar Asset Management Partners Inc.	31,354	$1.32M	0.0%	N/A	0.046%
2/19/2025	GF Fund Management CO. LTD.	1,438	$60K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	98,744	$4.15M	0.0%	+17.3%	0.144%
2/17/2025	VR Adviser LLC	592,411	$24.91M	1.7%	-34.8%	0.865%
2/17/2025	Woodline Partners LP	1,188,518	$49.98M	0.3%	+0.3%	1.736%
2/17/2025	Soleus Capital Management L.P.	312,321	$13.13M	0.8%	-21.6%	0.456%
2/17/2025	Squarepoint Ops LLC	19,440	$0.82M	0.0%	N/A	0.028%
2/17/2025	Wexford Capital LP	40,386	$1.70M	0.3%	+26.2%	0.059%
2/17/2025	Two Sigma Advisers LP	720,800	$30.31M	0.1%	-1.2%	1.053%
2/17/2025	Two Sigma Investments LP	507,741	$21.35M	0.0%	-14.4%	0.742%
2/17/2025	State of Wyoming	1,130	$48K	0.0%	N/A	0.002%
2/17/2025	Stempoint Capital LP	614,812	$25.85M	6.4%	+46.0%	0.898%
2/17/2025	Sphera Funds Management LTD.	130,532	$5.49M	1.0%	-11.6%	0.191%
2/17/2025	Polar Asset Management Partners Inc.	31,354	$1.32M	0.0%	N/A	0.046%
2/17/2025	Polar Capital Holdings Plc	1,706,238	$71.75M	0.4%	+34.7%	2.492%
2/17/2025	Paradigm Biocapital Advisors LP	1,689,922	$71.06M	2.5%	-31.2%	2.468%
2/17/2025	Parkman Healthcare Partners LLC	45,680	$1.92M	0.3%	+0.7%	0.067%
2/17/2025	Nuveen Asset Management LLC	36,422	$1.53M	0.0%	-2.6%	0.053%
2/17/2025	OMERS ADMINISTRATION Corp	10,600	$0.45M	0.0%	N/A	0.015%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	14,540	$0.61M	0.0%	+46.5%	0.021%
2/17/2025	Octagon Capital Advisors LP	308,000	$12.95M	2.1%	N/A	0.450%
2/17/2025	Millennium Management LLC	883,565	$37.15M	0.0%	+87.0%	1.291%
2/17/2025	Lazard Asset Management LLC	2,007	$84K	0.0%	N/A	0.003%
2/17/2025	J. Goldman & Co LP	7,001	$0.29M	0.0%	-82.7%	0.010%
2/17/2025	Janus Henderson Group PLC	21,290	$0.89M	0.0%	+12.7%	0.031%
2/17/2025	Granahan Investment Management LLC	104,562	$4.40M	0.2%	-7.7%	0.153%
2/17/2025	Fred Alger Management LLC	47,288	$1.99M	0.0%	-18.4%	0.069%
2/17/2025	Deutsche Bank AG	113,056	$4.75M	0.0%	+0.4%	0.165%
2/17/2025	D. E. Shaw & Co. Inc.	359,048	$15.10M	0.0%	-45.9%	0.524%
2/17/2025	DAFNA Capital Management LLC	451,804	$19M	4.8%	+9.5%	0.660%
2/17/2025	Deerfield Management Company L.P. Series C	2,972,787	$125.01M	2.4%	-12.8%	4.342%
2/17/2025	Driehaus Capital Management LLC	1,280,337	$53.84M	0.4%	-5.8%	1.870%
2/17/2025	Baker BROS. Advisors LP	450,000	$18.92M	0.2%	+50.0%	0.657%
2/17/2025	Balyasny Asset Management L.P.	33,399	$1.40M	0.0%	-94.4%	0.049%
2/17/2025	Bank of America Corp DE	37,805	$1.59M	0.0%	-40.9%	0.055%
2/17/2025	BNP Paribas Financial Markets	187,548	$7.89M	0.0%	-3.6%	0.274%
2/17/2025	Algert Global LLC	173,114	$7.28M	0.2%	+12.6%	0.253%

Data available starting January 2016

See Full Table

Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer and castration-resistant prostate cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; collaboration with Incyte Corporation for the development of MCLA-145; and collaboration with Gilead Sciences, Inc. to discover novel antibody-based trispecific T-cell engagers. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

Today's Range

Now: $51.70

$50.40

$57.66

50 Day Range

MA: $42.88

$34.89

$55.14

52 Week Range

Now: $51.70

$33.19

$61.28

Volume

1,829,418 shs

Average Volume

738,461 shs

Market Capitalization

$3.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Merus?: Merus' top insider shareholders include:
Harry Shuman (VP)
Peter B Silverman (COO)
Learn More about top insider investors at Merus.
Who are the major institutional investors of Merus?: Merus' top institutional investors include:
Wellington Management Group LLP — 6.82%
Paradigm Biocapital Advisors LP — 4.87%
Samlyn Capital LLC — 3.44%
Westfield Capital Management Co. LP — 2.17%
Woodline Partners LP — 2.02%
Driehaus Capital Management LLC — 1.81%
Learn More about top institutional investors of Merus stock.
Which institutional investors are selling Merus stock?: In the previous quarter, MRUS stock was sold by these institutional investors:
Federated Hermes Inc.
T. Rowe Price Investment Management Inc.
Millennium Management LLC
Samlyn Capital LLC
Baker BROS. Advisors LP
Tri Locum Partners LP
Goldman Sachs Group Inc.
Alyeska Investment Group L.P.
During the previous year, company insiders that have sold Merus company stock include:
Harry Shuman (VP)
Peter B Silverman (COO)
Learn More investors selling Merus stock.
Which institutional investors are buying Merus stock?: During the last quarter, MRUS stock was bought by institutional investors including:
Paradigm Biocapital Advisors LP
Wellington Management Group LLP
Westfield Capital Management Co. LP
Siren L.L.C.
Woodline Partners LP
Carmignac Gestion
Allostery Investments LP
Aberdeen Group plc